Free Trial

Establishment Labs (ESTA) Competitors

Establishment Labs logo
$40.01 +1.07 (+2.75%)
(As of 12/20/2024 05:16 PM ET)

ESTA vs. PRCT, AXNX, NVCR, NVST, NARI, IRTC, LIVN, ENOV, WRBY, and CNMD

Should you be buying Establishment Labs stock or one of its competitors? The main competitors of Establishment Labs include PROCEPT BioRobotics (PRCT), Axonics (AXNX), NovoCure (NVCR), Envista (NVST), Inari Medical (NARI), iRhythm Technologies (IRTC), LivaNova (LIVN), Enovis (ENOV), Warby Parker (WRBY), and CONMED (CNMD). These companies are all part of the "medical equipment" industry.

Establishment Labs vs.

Establishment Labs (NASDAQ:ESTA) and PROCEPT BioRobotics (NASDAQ:PRCT) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their community ranking, earnings, dividends, institutional ownership, profitability, valuation, analyst recommendations, media sentiment and risk.

Establishment Labs has a beta of 1.16, indicating that its stock price is 16% more volatile than the S&P 500. Comparatively, PROCEPT BioRobotics has a beta of 0.99, indicating that its stock price is 1% less volatile than the S&P 500.

Establishment Labs has a net margin of -46.13% compared to PROCEPT BioRobotics' net margin of -50.07%. PROCEPT BioRobotics' return on equity of -38.57% beat Establishment Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
Establishment Labs-46.13% -184.55% -24.81%
PROCEPT BioRobotics -50.07%-38.57%-26.06%

Establishment Labs received 79 more outperform votes than PROCEPT BioRobotics when rated by MarketBeat users. However, 67.86% of users gave PROCEPT BioRobotics an outperform vote while only 61.90% of users gave Establishment Labs an outperform vote.

CompanyUnderperformOutperform
Establishment LabsOutperform Votes
117
61.90%
Underperform Votes
72
38.10%
PROCEPT BioRoboticsOutperform Votes
38
67.86%
Underperform Votes
18
32.14%

Establishment Labs currently has a consensus target price of $60.60, suggesting a potential upside of 51.46%. PROCEPT BioRobotics has a consensus target price of $97.86, suggesting a potential upside of 20.56%. Given Establishment Labs' stronger consensus rating and higher possible upside, analysts clearly believe Establishment Labs is more favorable than PROCEPT BioRobotics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Establishment Labs
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.00
PROCEPT BioRobotics
0 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.86

In the previous week, PROCEPT BioRobotics had 2 more articles in the media than Establishment Labs. MarketBeat recorded 4 mentions for PROCEPT BioRobotics and 2 mentions for Establishment Labs. PROCEPT BioRobotics' average media sentiment score of 1.35 beat Establishment Labs' score of 0.95 indicating that PROCEPT BioRobotics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Establishment Labs
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
PROCEPT BioRobotics
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Establishment Labs has higher earnings, but lower revenue than PROCEPT BioRobotics. PROCEPT BioRobotics is trading at a lower price-to-earnings ratio than Establishment Labs, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Establishment Labs$153.07M7.32-$78.50M-$2.58-15.51
PROCEPT BioRobotics$199.84M21.20-$105.90M-$1.95-41.63

72.9% of Establishment Labs shares are held by institutional investors. Comparatively, 89.5% of PROCEPT BioRobotics shares are held by institutional investors. 11.4% of Establishment Labs shares are held by company insiders. Comparatively, 17.4% of PROCEPT BioRobotics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

PROCEPT BioRobotics beats Establishment Labs on 10 of the 19 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ESTA vs. The Competition

MetricEstablishment LabsSurgical appliances & supplies IndustryMedical SectorNASDAQ Exchange
Market Cap$1.12B$9.53B$5.14B$9.08B
Dividend YieldN/A1.38%5.09%4.23%
P/E Ratio-15.5119.5689.9717.18
Price / Sales7.3232.801,116.21116.99
Price / CashN/A22.3742.8937.86
Price / Book56.355.494.784.78
Net Income-$78.50M$182.72M$120.23M$225.60M
7 Day Performance-13.02%-4.48%-1.92%-1.23%
1 Month Performance-6.10%-4.23%11.49%3.36%
1 Year Performance65.74%-12.17%30.57%16.60%

Establishment Labs Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ESTA
Establishment Labs
2.5211 of 5 stars
$40.01
+2.7%
$60.60
+51.5%
+73.3%$1.12B$153.07M-15.51960Positive News
PRCT
PROCEPT BioRobotics
2.7595 of 5 stars
$89.54
+0.3%
$97.86
+9.3%
+102.9%$4.67B$136.19M0.00626Positive News
AXNX
Axonics
1.4204 of 5 stars
$70.98
+0.8%
$71.00
+0.0%
+20.9%$3.63B$366.38M-591.45610High Trading Volume
NVCR
NovoCure
2.4915 of 5 stars
$32.84
-1.7%
$32.67
-0.5%
+138.4%$3.55B$577.74M-23.861,453
NVST
Envista
3.9074 of 5 stars
$19.59
+0.6%
$20.65
+5.4%
-21.1%$3.37B$2.50B-2.5112,800Positive News
NARI
Inari Medical
3.3112 of 5 stars
$55.39
-0.4%
$58.89
+6.3%
-11.9%$3.24B$574.50M-41.181,300Analyst Forecast
Insider Trade
IRTC
iRhythm Technologies
3.0956 of 5 stars
$89.50
+3.6%
$107.82
+20.5%
-14.3%$2.80B$492.68M-17.782,000Analyst Forecast
LIVN
LivaNova
3.626 of 5 stars
$50.15
-2.6%
$69.17
+37.9%
-4.4%$2.72B$1.24B122.622,900Analyst Upgrade
Positive News
ENOV
Enovis
2.9726 of 5 stars
$46.56
+0.9%
$67.00
+43.9%
-21.5%$2.60B$2.00B-21.396,550Positive News
WRBY
Warby Parker
1.5771 of 5 stars
$24.24
+2.6%
$20.73
-14.5%
+99.1%$2.46B$669.77M-87.523,491Insider Trade
CNMD
CONMED
4.6139 of 5 stars
$71.69
-1.2%
$79.80
+11.3%
-36.7%$2.21B$1.29B17.234,000Positive News

Related Companies and Tools


This page (NASDAQ:ESTA) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners